Pharmaceutical Packaging Market - By Packaging Type (Blister Packs, Bottles, Syringes, Vials & Ampoules, Sachets), By Material Type (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil), By End Use & Forecast, 2023

Description

List of Tables

Global Pharmaceutical Packaging Market will register a 13% CAGR from 2023 to 2032, attributed to advancements in drug delivery technologies and packaging materials. Innovations in drug administration methods and materials that enhance product safety and efficacy contribute significantly. With a focus on improving patient compliance and addressing complex therapeutic needs, the evolving landscape of drug delivery and packaging will play a pivotal role in expanding the pharmaceutical packaging industry and meeting the dynamic requirements of the pharmaceutical industry.

Companies are embracing technological advancements and introducing inventive packaging materials, thus fortifying their market share with enhanced security and efficiency. For instance, in 2023, Pluss Advanced Technologies (PLUSS), a company specializing in phase-change material (PCM) technology, introduced two novel temperature-controlled packaging solutions for the pharmaceutical sector: the Celsure® VIP Multi-Use Parcel Shipper series and the Celsure® XL Pallet Shipper series.

The pharmaceutical packaging industry is classified based on packaging type, material type, and region.

The syringes segment will experience remarkable traction by 2032 due to the pivotal role they play in drug administration, ensuring precise dosage and enhancing patient safety. The increasing prevalence of injectable therapies, coupled with advancements in syringe design for convenience and accuracy, will further propel their market prominence. As healthcare trends lean towards injectable treatments, syringes stand as a crucial component, driving their significant presence in the evolving landscape of pharmaceutical packaging.

The pharmaceutical packaging market revenue from the plastics and polymers segment will witness a substantial upswing by 2032, fueled by their versatility, providing lightweight, durable, and cost-effective packaging solutions. The increasing adoption of plastic materials for drug packaging due to their compatibility with various formulations and superior barrier properties, will contribute to their market prominence. As the pharmaceutical industry seeks sustainable and efficient packaging options, plastics and polymers will emerge as integral components, driving their significant presence in the evolving landscape of pharmaceutical packaging.

Europe pharmaceutical packaging industry will demonstrate a significant CAGR from 2023 to 2032, driven by its robust pharmaceutical sector and stringent regulatory standards. The region's advanced healthcare infrastructure and emphasis on innovative packaging solutions will contribute significantly to this dominance. With a commitment to quality and sustainability, Europe will play a vital role in shaping the pharmaceutical packaging market, meeting the evolving demands of the global healthcare industry, and emerging as a key contributor to the industry's growth.

Product Code: 5256

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Pharmaceutical packaging market 360 degree synopsis, 2018 - 2032
2.2 Business trends
- 2.2.1 Total addressable market (TAM), 2023-2032
2.3 Regional trends
2.4 Packaging type trends
2.5 Material type trends
2.6 End-use trends

Chapter 3 Pharmaceutical Packaging Industry Insights

3.1 Impact on COVID-19
3.2 Russia-Ukraine war impact
3.3 Industry ecosystem analysis
3.4 Vendor matrix
3.5 Profit margin analysis
3.6 Material type & innovation landscape
3.7 Patent analysis
3.8 Key news and initiatives
3.9 Regulatory landscape
3.10 Impact forces
- 3.10.1 Growth drivers
  - 3.10.1.1 Rising consumer preferences for healthier lifestyle
  - 3.10.1.2 Increasingly use of advanced drug delivery systems
  - 3.10.1.3 Growing demand for nano drug delivery systems
  - 3.10.1.4 Growing use of generic medications in developing countries
  - 3.10.1.5 Increasing innovation of Novel drug packaging systems
- 3.10.2 Industry pitfalls & challenges
  - 3.10.2.1 Counterfeit drugs and fake packaging
  - 3.10.2.2 Limited or Inadequate access to quality medical care
3.11 Growth potential analysis
3.12 Porter's analysis
3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company market share, 2022
4.3 Competitive analysis of major market players, 2022
- 4.3.1 Amcor plc
- 4.3.2 Berry Global, Inc.
- 4.3.3 Catalent, Inc.
- 4.3.4 Drug Plastics Group
- 4.3.5 Gerresheimer AG
- 4.3.6 Schott AG
4.4 Competitive positioning matrix, 2022
4.5 Strategic outlook matrix, 2022

Chapter 5 Pharmaceutical Packaging Market Estimates and Forecast, By Packaging Type 2018-2032 (USD Million)

5.1 Key trends, by packaging type
5.2 Blister Packs
5.3 Bottles
5.4 Syrings
5.5 Vials & Ampoules
5.6 Sachets
5.7 Others

Chapter 6 Pharmaceutical Packaging Market Estimates and Forecast, By Material type 2018-2032 (USD Million)

6.1 Key trends, by material type
6.2 Plastics & Polymers
6.3 Paper & Paperboard
6.4 Glass
6.5 Aluminium Foil
6.6 Others

Chapter 7 Pharmaceutical Packaging Market Estimates and Forecast, By End-use 2018-2032 (USD Million)

7.1 Key trends, by end-use
7.2 Pharma Manufacturing
7.3 Contract Packaging
7.4 Retail Pharmacy
7.5 Institutional Pharmacy

Chapter 8 Pharmaceutical Packaging Market Estimates and Forecast, By Region 2018-2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 UK
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 ANZ
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of MEA

Chapter 9 Company Profiles (Business Overview, Financial Overview, Product Landscape, Strategic Outlook, SWOT Analysis)

9.1 Amcor plc
9.2 Becton, Dickinson, and Company
9.3 AptarGroup, Inc.
9.4 Drug Plastics Group
9.5 Gerresheimer AG
9.6 Schott AG
9.7 Owens Illinois, Inc.
9.8 West Pharmaceutical Services, Inc.
9.9 Berry Global, Inc.
9.10 WestRock Company
9.11 SGD Pharma
9.12 International Paper
9.13 Comar, LLC
9.14 CCL Industries, Inc.
9.15 Vetter Pharma International
9.16 Gerresheimer AG
9.17 Catalent, Inc.
9.18 WestRock